Recipharm invests EUR 2.6 million in Kaysersberg facility
Global contract development and manufacturing organisation (CDMO), Recipharm, has announced a EUR 2.6 million investment for additional manufacturing capacity to support increased demand into its Kaysersberg facility. This investment in the Kaysersberg facility, located in the Alsace region of France, will add additional capacity and capabilities for the company’s customers, as the company continues to secure new business for the future. This latest investment is part of Recipharm’s phased expansion plan for the facility. Yves Buelens, General Manager at the Kaysersberg facility, said: